Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma
Clinical trial NCT02784483 · TERMINATED
Trial details
- NCT number
- NCT02784483
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-10
- Primary completion
- 2017-09-15
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.